Genome-wide functions of PML–RARα in acute promyelocytic leukaemia
2011
Genome-wide functions of PML–RARα in acute promyelocytic leukaemia
publication
Evidence: moderate
Author Information
Author(s): Saeed S, Logie C, Stunnenberg H G, Martens J H A
Primary Institution: Radboud University
Conclusion
The study highlights the complex roles of the PML–RARα fusion protein in acute promyelocytic leukaemia, particularly its genome-wide binding and regulation of epigenetic modifications.
Supporting Evidence
- PML–RARα is found in over 95% of human APL cases.
- Recent studies have identified nearly 3000 genome-wide direct targets of PML–RARα.
- ATRA and ATO are important drugs that degrade the PML–RARα fusion protein.
Takeaway
This study looks at how a specific protein involved in a type of leukemia works in the body and affects other genes.
Methodology
The review discusses findings from recent studies using high-throughput sequencing and array-based technologies to analyze PML–RARα binding sites.
Limitations
The review is based on existing studies and may not cover all aspects of PML–RARα functions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website